The U.S. Food and Drug Administration has approved the application of Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) to help manage chronic obesity in adults with a body mass index (BMI) of greater than 27, given that they also experience weight-related health issues such as Tupe2 diabestes, high-cholesterol and/or hypertension (high blood pressure levels).Contrave is a combination of two FDA-approved drugs, naltrexone and bupropion, within an extended-release formulation. Naltrexone is approved to treat alcohol and opioid dependence. Bupropion is eligible to treat depression and seasonal affective disorder and as an aid to smoking cessation treatment.'Obesity may be a major public health concern,' said Jean-Marc Guettier, M.D., director in the Division of Metabolism and Endocrinology Products in FDA's Center for Drug Evaluation and Research. 'When used as directed in combination with a healthy lifestyle which includes a reduced-calorie eating and working out, Contrave provides another treatment choice for chronic weight-loss for people who are obese or are overweight and possess at least one weight-related health problem.'The drug's effectiveness was evaluated in multiple numerous studies that included approximately 4,500 obese and overweight patients with and without significant weight-related conditions treated for just one year. All patients received lifestyle modification that contains a reduced- calorie diet and regular exercising. Results from a clinical study that enrolled patients without diabetes indicated that patients had the average weight loss of 4.1% instead of participants who were given placebos) during a 12- month period, while an outside study involving patients with type 2 diabetes had a normal weight loss of 2% over treatment with placebo at twelve months.
Using two separate drugs to lose weight can be very effective there are combinations as you're watching FDA now awaiting approval. When dealing with weight-loss and the those who go through it you need to err assisting caution and let the FDA do its job and demand some research be done so that the public knows the side effects and dangers of the medications before we drive them. Keep in mind that drug companies come in business to make money and that they would say everything to keep people on his or her medications.
Researchers discovered that participants taking this drug for a year, dropped excess weight within one month and have kept the weight off through the entire 56 weeks from the study. Contrave is really a combination with the drugs naltrexone and bupropion, which seems to reflect a whole new trend of weight-loss drugs that are made up of several active ingredient, which may make them far better and safer.
Combo-pilling is the newest fad or in addition to this the newest in the future under scrutiny and therefore it is just more publicly known recently, comb-pilling for weight reduction has been around since the eighties. The biggest reason that using a combination of pills has become popular may be the fact that by right now there aren't long term prescription slimming capsules that have been authorized by the FDA aside from orlistat. The truly disturbing part is always that doctors are prescribing these combinations of medications even though some of the combinations have been rejected or have yet to be authorized by the FDA.
Seizures are a side effect with Contrave and shouldn't be taken in people with seizure disorders. The drug could also raise blood pressure level and heart rate, and shouldn't be used in people with a history of cardiac arrest or stroke in the previous six months. Blood pressure and pulse should also be measured prior to starting the drug and throughout therapy using the drug.
The FDA also warned that Contrave can raise blood pressure and heartrate and must not used in patients with uncontrolled high blood pressure level, as well as by a person with heart-related and cerebrovascular (circulatory dysfunction impacting your brain) disease. Patients using a history of cardiac arrest or stroke in the last six months, life-threatening arrhythmias, or congestive heart failure were excluded from your clinical trials. Those taking Contrave must have their heart-rate and pulse monitored regularly. In addition, since the compound includes bupropion, Contrave comes with a boxed warning to alert medical researchers and patients on the increased chance of suicidal thoughts and behaviors linked to antidepressant drugs. The warning also notes that serious neuropsychiatric events are actually reported in patients taking bupropion for stop smoking.
A pyromaniac, with both psychiatric and medical therapy, can nevertheless be treated. It is best done with behavioral therapy. Psychotherapy treatment alongside behavior modification is regarded as the frequently used treatment. Based on the study of Jon Grant, a mix treatment of drugs and behavioral therapy was discovered to be successful for pyromania. The usage of serotonin reuptake inhibitors can be beneficial in controlling the impulsive behavior with the patient such as other impulse control disorder. Also great for the patient are medications for example Lithium, naltrexone, (ReVia), fluoxetine (Prozac), citalopram (Celexa), paroxetene (Paxil), and other antidepressants.